Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Gyawali, Bishal; Ferrario, Alessandra; Teijlingen, Edwin van; Kallestrup, Per (2016)
Publisher: Co-Action Publishing
Journal: Global Health Action
Languages: English
Types: Article
Subjects: Public Health; Global Health; Health Systems; Community Health, diabetes mellitus type 2; diabetes complications; costs; low-income country; health care; Nepal
Background and objectives: Diabetes has become an increasingly prevalent and severe public health problem in Nepal. The Nepalese health system is struggling to deliver comprehensive, quality treatment and services for diabetes at all levels of health care. This study aims to review evidence on the prevalence, cost and treatment of diabetes mellitus type 2 and its complications in Nepal and to critically assess the challenges to be addressed to contain the epidemic and its negative economic impact.Design: A comprehensive review of available evidence and data sources on prevalence, risk factors, cost, complications, treatment, and management of diabetes mellitus type 2 in Nepal was conducted through an online database search for articles published in English between January 2000 and November 2015. Additionally, we performed a manual search of articles and reference lists of published articles for additional references.Results: Diabetes mellitus type 2 is emerging as a major health care problem in Nepal, with rising prevalence and its complications especially in urban populations. Several challenges in diabetes management were identified, including high cost of treatment, limited health care facilities, and lack of disease awareness among patients. No specific guideline was identified for the prevention and treatment of diabetes in Nepal.Conclusions: We conclude that a comprehensive national effort is needed to stem the tide of the growing burden of diabetes mellitus type 2 and its complications in Nepal. The government should develop a comprehensive plan to tackle diabetes and other non-communicable diseases supported by appropriate health infrastructure and funding.Keywords: diabetes mellitus type 2; diabetes complications; costs; low-income country; health care; Nepal(Published: 18 October 2016)Citation: Glob Health Action 2016, 9: 31704 - http://dx.doi.org/10.3402/gha.v9.31704
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Non communicable diseases fact sheet. 2015. Available from: http://www.who.int/mediacentre/factsheets/fs355/en/ [cited 29 December 2015].
    • 2. The global status on non-communicable diseases: a new WHO report. 2011. Available from: http://www.who.int/nmh/ publications/ncd_report_full_en.pdf [cited 29 December 2015].
    • 3. Miranda JJ, Kinra S, Casas JP, Smith GD, Ebrahim S. Noncommunicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health 2008; 13: 1225 34.
    • 4. The growing danger of non-communicable diseases acting now to reverse course. 2011. Available from: http://siteresources. worldbank.org/HEALTHNUTRITIONANDPOPULATION/ Resources/Peer-Reviewed-Publications/WBDeepeningCrisis.pdf [cited 29 December 2015].
    • 5. Diabetes atlas sixth edition poster update 2014. Brussels, Belgium: International Diabetes Federation; 2014.
    • 6. Nepal GDP-per capita (PPP). 2015. Available from: http://www. indexmundi.com/nepal/gdp_per_capita_(ppp).html [cited 29 February 2016].
    • 7. CBS (2011). National population and housing census 2011 (national report). Kathmandu, Nepal: Central Bureau of Statistics.
    • 8. World Bank (2013). Urban growth and spatial transition: an initial assessment. Washington, DC: World Bank.
    • 9. CBS (2011). Nepal Living Standards Survey 2010 2011, NLSS Third. Kathmandu, Nepal: Central Bureau of Statistics, Government of Nepal.
    • 10. World development indicators. The World Bank; 2013. Available from: http://data.worldbank.org/country/nepal [cited 30 December 2015].
    • 11. CBS (2014). Statistical pocket book of Nepal. Kathmandu, Nepal: Central Bureau of Statistics.
    • 12. Bhandari GP, Angdembe MR, Dhimal M, Neupane S, Bhusal C. State of non-communicable diseases in Nepal. BMC Public Health 2014; 14: 1 9.
    • 13. Bhandari G, Neupane S, Ghimire U, Khanal A. Prevalence of non communicable disease in Nepal. Kathmandu: Nepal Health Research Council; 2010.
    • 14. WHO (2014). Noncommunicable diseases (NCD) country profiles, 2014. Available from: http://www.who.int/nmh/countries/ npl_en.pdf [cited 3 February 2016].
    • 15. Gyawali B, Sharma R, Neupane D, Mishra SR, van Teijlingen E, Kallestrup P. Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014. Glob Health Action 2015; 8: 29088, doi: http://dx.doi.org/10.3402/ gha.v8.29088
    • 16. IDF Diabetes Atlas: country estimates table 2011. 2012. Available from: http://www.idf.org/sites/default/ [cited 16 December 2015].
    • 17. Society for Local Integrated Development Nepal (SOLID Nepal), Merlin Nepal (2012). Barriers to effective policy implementation and management of human resources for health in Nepal. Kathmandu, Nepal: SOLID Nepal.
    • 18. Ministry of Health & Population (MoHP), Nepal Health Sector Support Programme. Human resources for health Nepal Country Profile. Kathmandu: MoHP; 2013.
    • 19. Dhitali SM, Arjun K. Dealing with the burden of hypertension in Nepal: current status, challenges and health system issues. Reg Health Forum. 2013; 17(1): 44 52.
    • 20. World Health Organization (2015). Global health expenditure database. Available from: http://apps.who.int/nha/database/ ViewData/Indicators/en [cited 4 February 2016].
    • 21. World Bank. Out-of-pocket health expenditure (% of private expenditure on health). Available from: http://data.worldbank. org/indicator/SH.XPD.OOPC.ZS/countries [cited 14 December 2015].
    • 22. Ministry of Health and Population (2014). New national health policy. Kathmandu, Nepal: Ministry of Health and Population.
    • 23. Adhikari S. An evaluation of Nepal's free health care scheme: evidence from a quasi-experimental design. Soc Sci Res Net 2013. doi: http://dx.doi.org/10.2139/ssrn.2289344
    • 24. Aryal KK, Neupane S, Mehata S, Vaidya A, Singh S, Paulin F. Non communicable diseases risk factors: STEPS Survey Nepal 2013. Kathmandu, Nepal: Nepal Health Research Council; 2014.
    • 25. Saito E, Gilmour S, Rahman MM, Gautam GS, Shrestha PK, Shibuya K. Catastrophic household expenditure on health in Nepal: a cross-sectional survey. Bull World Health Organ 2014; 92: 760 7.
    • 26. Government of Nepal (2013). Multisectoral action plan for the prevention and control of non-communicable diseases (2014 2020). Kathmandu, Nepal: Government of Nepal.
    • 27. Aryal KK, Mehata S, Neupane S, Vaidya A, Dhimal M, Dhakal P, et al. The burden and determinants of non communicable diseases risk factors in Nepal: findings from a nationwide STEPS survey. PLoS One 2015; 10: e0134834.
    • 28. Prasai DP. A review of studies on Nepal's national free health care programme. Kathmandu, Nepal: Primary Health Care Revitalization Division, Department of Health Services, Ministry of Health and Population, Nepal; 2013.
    • 29. Rajbhandari S. Diabetes in Nepal-future and perspective. PowerPoint presentation; 2010. Available from: http://www.diabetesnepal.org/For_Professsionals/C2010/EASDADA presentation 2010/01 Rajbhandari (Nepal).pdf [cited 20 December 2015].
    • 30. Baral N, Koner BC, Karki P, Ramaprasad C, Lamsal M, Koirala S. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population-the implications of measuring glycated hemoglobin. Singapore Med J 2000; 41: 264 7.
    • 31. Karki P, Baral N, Lamsal M, Rijal S, Koner BC, Dhungel S, et al. Prevalence of non-insulin dependent diabetes mellitus in urban areas of eastern Nepal: a hospital based study. Southeast Asian J Trop Med Public Health 2000; 31: 163 6.
    • 32. Singh DL, Bhattarai MD. High prevalence of diabetes and impaired fasting glycaemia in urban Nepal. Diabet Med 2003; 20: 170 1.
    • 33. Jha N. Cost analysis for management of type-2 diabetes: a case study of rural and urban setting. J Nepal Health Res Counc 2004; 2: 55 59.
    • 34. Sasaki H, Kawasaki T, Ogaki T, Kobayashi S, Itoh K, Yoshimizu Y, et al. The prevalence of diabetes mellitus and impaired fasting glucose/glycaemia (IFG) in suburban and rural Nepal-the communities based cross-sectional study during the democratic movements in 1990. Diabetes Res Clin Pract 2005; 67: 167 74.
    • 35. Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med 2006; 23: 1130 5.
    • 36. Mehta RS, Karki P, Sharma SK. Risk factors, associated health problems, reasons for admission and knowledge profile of diabetes patients admitted in BPKIHS. Kath Univ Med J. 2006; 4: 11 13.
    • 37. Ono K, Limbu YR, Rai SK, Kurokawa M, Yanagida J, Rai G, et al. The prevalence of type 2 diabetes mellitus and impaired fasting glucose in semi-urban population of Nepal. Nepal Med Coll J 2007; 9: 154 6.
    • 38. Kart CS, Kinney JM, Subedi J, Basnyat KB, Vadakkan MF. Lay explanations and self-management of diabetes in Kathmandu, Nepal. J Aging Health 2007; 19: 683 704.
    • 39. Upadhyay DK, Palaian S, Ravi Shankar P, Mishra P, Shah K. Prescribing pattern in diabetic outpatients in a tertiary care teaching hospital in Nepal. J Clin Diag Res 2007; 1: 248 55.
    • 40. Shrestha MK, Paudyal G, Wagle RR, Gurung R, Ruit S, Onta SR. Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: a hospital based study. Nepal Med Coll J 2007; 9: 225 9.
    • 41. Upadhyay DK, Palaian S, Shankar PR, Mishra P. Knowledge, attitude and practice about diabetes among diabetes patients in western Nepal. RMJ 2008; 33: 8 11.
    • 42. Paudyal G, Shrestha MK, Meyer JJ, Thapa R, Gurung R, Ruit S. Prevalence of diabetic retinopathy following a community screening for diabetes. Nepal Med Coll J 2008; 10: 160 3.
    • 43. Chettri MR, Chapman RS. Prevalence and determinants of diabetes among the elderly population in the Kathmandu Valley of Nepal. Nepal Med Coll J 2009; 11: 34 8.
    • 44. Sharma SK, Ghimire A, Radhakrishnan J, Thapa L, Shrestha NR, Paudel N, et al. Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens 2011; 2011: 821971.
    • 45. Thapa R, Poudyal G, Maharjan N, Bernstein PS. Demographics and awareness of diabetic retinopathy among diabetic patients attending the vitreo-retinal service at a tertiary eye care center in Nepal. Nepal J Opthalmol 2012; 4: 10 16.
    • 46. Sharma SK, Dhakal S, Thapa L, Ghimire A, Tamrakar R, Chaudhary S, et al. Community-based screening for chronic kidney disease, hypertension and diabetes in Dharan. Nepal J Med Assoc 2013; 52: 205 12.
    • 47. Shrestha N, Lohani SP, Angdembe MR, Bhattarai K, Bhattarai J. Cost of diabetes mellitus care among patients attending selected outpatient clinics. JNMA J Nepal Med Assoc 2013; 52: 343 8.
    • 48. Parajuli J, Saleh F, Thapa N, Ali L. Factors associated with nonadherence to diet and physical activity among Nepalese type 2 diabetes patients; a cross sectional study. BMC Res Notes 2014; 7: 758.
    • 49. Poudel A. Government expands essential drugs list, focus shifts to non-communicable diseases. My Republica; 24 February 2014. Available from: http://www.nepalresearch.com/health/ pharmaceutics.html [cited 2 February 2015].
    • 50. Poudel RR. Diabetes and Endocrinology in Nepal. Indian J Endocrinol Metab 2014; 18: 118 19.
    • 51. Gautam A, Bhatta DN, Aryal UR. Diabetes related health knowledge, attitude and practice among diabetic patients in Nepal. BMC Endocr Disord 2015; 15: 25.
    • 52. Maskey R, Shakya DR, Baranwal JK, Lavaju P, Karki P, Poudel SK. Hypothyroidism in diabetes mellitus patients in Eastern Nepal. Indian J Endocrinol Metab 2015; 19: 411 15.
    • 53. Mishra SR, Sharma A, Bhandari PM, Bhochhibhoya S, Thapa K. Depression and health-related quality of life among patients with type 2 diabetes mellitus: a cross-sectional study in Nepal. PLoS One 2015; 10: e0141385.
    • 54. Joshi S, Dhungana RR, Subba UK. Illness perception and depressive symptoms among persons with Type 2 Diabetes Mellitus: an analytical cross-sectional study in clinical settings in Nepal. J Diabetes Res 2015; 2015: 9.
    • 55. Kalra S, Aamir AH, Raza A, Das AK, Azad Khan AK, Shrestha D, et al. Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: a consensus statement. Indian J Endocrinol Metab 2015; 19: 577 96.
    • 56. WHO (2007). Health system in Nepal: challenges and strategic options. New Delhi: WHO-SEARO. WHO, Regional Office for South-East Asia.
    • 57. GIZ (2012). Review of community-based health insurance initiatives in Nepal. Kathmandu, Nepal: GIZ Nepal.
    • 58. WHO (2009). World health statistics. Geneva: WHO Office.
    • 59. NDA. Nepal country information. 2014. Available from: http:// www.nepaldiabetesassociation.com/ [cited 15 February 2016].
    • 60. Astha Nepal. Association for social transformation and humanitarian assistance Nepal. 2013. Available from: http://www. astha-nepal.com/ [cited 15 February 2016].
    • 61. IRIN News (2013). Nepal sees growing threat of noncommunicable diseases. IRIN. Available from: http://www. irinnews.org/analysis/2013/09/03/nepal-sees-growing-threat-noncommunicable-diseases [cited 20 February 2016].
    • 62. IDF (2015). IDF diabetes atlas seventh edition. Brussels, Belgium: IDF.
    • 63. Bhuvan KC, Heydon S, Norris P. Access to and quality use of non-communicable diseases medicines in Nepal. J Pharma Policy Pract 2015; 8: 21.
    • 64. Acharya KG, Shah KN, Solanki ND, Rana DA. Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: a prospective, cross-sectional study at a tertiary care teaching hospital. J Basic Clin Pharm 2013; 4: 82 7.
    • 65. Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 2007; 85: 279 88.
    • 66. Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes 2003; 21: 175 8.
    • 67. WHO (2007). Strengthening health systems to improve health outcomes: WHO's framework for action. Geneva: World Health Organization.
    • 68. Ministry of Finance. Budget speech of fiscal year, 2011 2012. Kathmandu: Ministry of Finance (GoN); 2011. Cited in Bhuvan KC, Heydon S, Norris P. Access to and quality use of non-communicable diseases medicines in Nepal. J Pharm Policy Pract 2015; 8: 21.
    • 69. Ministry of Health and Population (2014). Increasing the number of free essential medicines to 70. Kathmandu: Ministry of Health and Population, Government of Nepal.
    • 70. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet 2008; 372: 940 9.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.

Share - Bookmark

Cite this article

Collected from